查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1414179

2024 年全球給藥系統市場報告

Drug Infusion Systems Global Market Report 2024
出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，給藥系統市場規模一直強勁成長。預計將從2023年的128億美元成長到2024年的137.8億美元，複合年成長率為7.6%。過去一段時間的擴張歸因於電子輸液設備的轉變、慢性病盛行率的上升、患者照護的進步、家庭輸液療法的採用以及門診護理環境的擴大。

醫療保健支出的增加預計將推動藥物劑量系統市場的擴張。健康支出是在特定時期（通常是一年）內用於醫療商品和服務的總金額。隨著醫療保健支出的增加，醫院、診所和其他醫療保健組織有更多的資源投資於先進的藥物管理系統，增加了對這些設備的需求。例如，2022年7月，根據經合組織《2022年衛生統計》，2021年衛生支出平均成長約6%。此外，2022 年 5 月，摩根大通的一份報告發現，2021 年整體醫療支出增加了 23%。因此，醫療保健支出的成長趨勢預計將推動藥物劑量系統市場的成長。

2023 年給藥系統市場最大的地區是北美。在預測期內，亞太地區預計將成為全球藥物注射系統市場報告中成長最快的地區。給藥系統市場報告涵蓋的地區包括亞太地區、西歐、東歐、北美、南美以及中東和非洲。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 市場促進因素/市場抑制因素
    • 市場促進因素
    • 市場抑制因素
  • 2018-2023 年市場規模與成長表現
  • 2023-2028、2033 年市場規模與成長預測

第6章市場區隔

  • 全球藥物系統市場，依產品、性能及預測細分，2018-2023、2023-2028、2033
  • 合成橡膠輸液系統
  • 一次性輸液系統
  • 注射器注射系統
  • 蠕動幫浦
  • 多通道泵浦
  • 聚氯乙烯泵
  • 胰島素幫浦
  • 植入式輸液系統
  • 全球藥物系統市場，依給藥途徑細分、績效與預測，2018-2023、2023-2028、2033
  • 靜脈
  • 皮下的
  • 動脈
  • 硬膜外
  • 其他
  • 全球藥物劑量系統市場，按應用、性能和預測細分，2018-2023、2023-2028、2033
  • 腫瘤/化療
  • 糖尿病
  • 緩解疼痛
  • 營養
  • 血
  • 小兒科
  • 其他
  • 全球藥物系統市場，按最終用戶細分，實際和預測，2018-2023、2023-2028、2033
  • 醫院
  • 門診手術中心
  • 診斷中心
  • 其他

第 7 章 區域與國家分析

  • 全球藥物注射系統市場，按地區、實際和預測，2018-2023、2023-2028、2033
  • 全球藥物系統市場，依國家、績效及預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭形勢及公司概況

  • 給藥系統市場競爭形勢
  • 給藥系統市場公司概況
    • Medtronic plc
    • Baxter International Inc.
    • ICU Medical Inc.
    • Becton Dickinson and Company
    • Smiths Group plc

第31章競爭基準化分析

第 32 章競爭對手儀表板

第33章 重大併購

第34章 未來前景與可能性分析

第35章附錄

簡介目錄
Product Code: r11689

“Drug Infusion Systems Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug infusion systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug infusion systems? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The drug infusion systems market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product Type: Elastomeric Infusion System; Disposable Infusion System; Syringe Infusion System; Peristaltic Pump; Multi-Channel Pump; Patient-Controlled Analgesia (PCA) Pump; Insulin Pump; Implantable Infusion System
  • 2) By Route Of Administration: Intravenous; Subcutaneous; Arterial; Epidural; Other Routes Of Administration
  • 3) By Application: Oncology And Chemotherapy; Diabetes; Analgesia; Nutrition; Hematology; Pediatrics; Other Applications
  • 4) By End User: Hospitals; Ambulatory Surgical Centers; Diagnostic Centers; Other End Users
  • Companies Mentioned: Medtronic plc; Baxter International Inc.; ICU Medical Inc.; Becton Dickinson and Company; Smiths Group plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Drug infusion systems, classified as medical devices, are instrumental in delivering medications and fluids into a patient's body through a catheter or needle. This method of administration is commonly employed in hospitals, clinics, and various healthcare settings to dispense medications such as pain relievers, antibiotics, chemotherapy drugs, and fluids to patients.

The primary categories of drug infusion systems encompass elastomeric infusion systems, disposable infusion systems, syringe infusion systems, peristaltic pumps, multi-channel pumps, patient-controlled analgesia (PCA) pumps, insulin pumps, and implantable infusion systems. Elastomeric infusion systems, for instance, are flexible containers designed to provide a consistent rate of medication delivery for short-term infusion therapy. They find application in hospitals, clinics, and home care settings for short-term drug infusion therapy. These systems are versatile, administered through various modes such as intravenous, subcutaneous, arterially, epidurally, and others. They cater to diverse medical applications, including oncology and chemotherapy, diabetes, analgesia, nutrition, hematology, pediatrics, and more. Various end-users, such as hospitals, ambulatory surgical centers, diagnostic centers, and others, utilize elastomeric infusion systems for their respective needs.

The drug infusion systems market research report is one of a series of new reports from The Business Research Company that provides drug infusion systems market statistics, including drug infusion systems industry global market size, regional shares, competitors with a drug infusion systems market share, detailed drug infusion systems market segments, market trends and opportunities, and any further data you may need to thrive in the drug infusion systems industry. This drug infusion systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The drug infusion systems market size has grown strongly in recent years. It will grow from $12.8 billion in 2023 to $13.78 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%.The expansion observed in the historical period can be ascribed to the transition towards electronic infusion devices, a rise in the prevalence of chronic diseases, advancements in patient care, the adoption of home-based infusion therapy, and the growth of ambulatory care settings.

The drug infusion systems market size is expected to see strong growth in the next few years. It will grow to $18.74 billion in 2028 at a compound annual growth rate (CAGR) of 8.0%. The anticipated growth in the forecast period can be linked to a shift towards disposable systems, a rising prevalence of chronic diseases, the expansion of ambulatory care facilities, the adoption of personalized medicine and adaptive dosing, and an increasing demand for home-based care. Noteworthy trends in the forecast period encompass wireless connectivity and remote monitoring, integration with electronic health records (EHR), the implementation of smart pump technology, the adoption of personalized and adaptive dosing, and the utilization of minimally invasive infusion techniques.

The anticipated growth in the drug infusion system market is expected to be propelled by the increasing prevalence of chronic diseases. Chronic conditions such as cancer, diabetes, cardiovascular diseases, and autoimmune disorders often necessitate long-term or continuous infusion therapy. Drug infusion systems provide a secure, efficient, and effective means of administering medication to patients with these conditions. The prevalence of chronic diseases is rising more rapidly in low- and middle-income countries compared to high-income nations. Diabetes, for example, is a significant contributor to renal failure, heart attacks, strokes, blindness, and lower limb amputation. According to the International Diabetes Federation (IDF), in 2021, 537 million adults aged between 20-79 were living with diabetes (1 in 10 individuals), and this number is projected to reach about 643 million by 2030 and 783 million by 2045. Therefore, the increasing demand due to the rising prevalence of chronic diseases is a driving factor for the growth of the drug infusion system market.

The growth of healthcare expenditure is expected to drive the expansion of the drug infusion systems market. Healthcare expenditure refers to the total amount spent on healthcare goods and services within a specific period, typically a year. With increased healthcare expenditures, hospitals, clinics, and other healthcare institutions have more resources to invest in advanced drug infusion systems, leading to a higher demand for these devices. For instance, in July 2022, according to OECD Health Statistics 2022, health spending increased by roughly 6% on average in 2021. Additionally, in May 2022, according to a JPMorgan Chase & Co. report, overall healthcare spending increased by 23% in 2021. Therefore, the upward trend in healthcare expenditure is expected to drive the growth of the drug infusion systems market.

The adoption of advanced drug delivery technologies stands out as a prominent trend in the drug infusion systems market. Leading companies in the market are actively engaged in developing innovative products that incorporate advanced technologies to maintain a competitive position. For example, in June 2021, Ivenix, a medical device company based in the United States, introduced a smart infusion system integrated with an advanced informatics platform. This infusion therapy system by Ivenix features new pump technology that automates secondary infusions, ensuring patients receive the complete prescribed therapy. The system also integrates a state-of-the-art informatics platform, allowing secure access to patient-specific infusion and pump management from any computer or mobile device. It seamlessly integrates with ADT interfacing, alarm notification systems, charge capture solutions, and electronic medical records (EMR) for smooth workflow integration.

Major players in the drug infusion systems market are directing their efforts towards developing innovative products, such as medication delivery systems, to gain a competitive advantage. Medication delivery systems encompass a diverse range of innovative tools and systems designed to enhance the safe, accurate, and efficient administration of medications. For instance, in February 2023, Mindray Medical International Limited, a China-based manufacturer of medical instrumentation, launched the BeneFusion i/u Series Infusion Systems. These systems provide unparalleled accuracy, adaptive customization, and remarkable simplicity, ensuring guaranteed medication safety in various clinical settings. The BolusGUARD motorized syringe loading system with patent-pending automatic clutch technology prevents loading errors, securing every step of the infusion process. The user-friendly interface and intuitive design streamline workflows and enhance the user experience.

In March 2022, Fresenius Kabi, a pharmaceutical company based in Germany, acquired Ivenix Inc. for $240 million. This strategic acquisition aims to expand Fresenius Kabi's portfolio of infusion therapy products and strengthen its position in the infusion system market. The acquisition positions Fresenius Kabi to offer a comprehensive and leading set of premium infusion therapy products for the benefit of patients, customers, and stakeholders. Ivenix, the acquired company, is a medical technology company based in the United States, specializing in the development of infusion systems.

Major companies operating in the drug infusion systems market report are Medtronic plc, Baxter International Inc., ICU Medical Inc., Becton Dickinson and Company, Smiths Group plc, Tandem Diabetes Care Inc., Terumo Corporation, Acromed AG, Halyard Health Inc., Insulet Corporation, Zyno Medical Inc., Braun Melsungen AG, Flowonix Medical Inc., IRadimed Corporation, Moog Inc., Debiotech S.A., Fresenius SE & Co. KGaA, Johnson & Johnson, Hospira, Alaris Health Systems Inc., B. Braun Melsungen AG, Disetronic Medical Systems AG, Accu-Chek, Abbott Diabetes Care Inc., Novo Nordisk A/S, Eli Lilly and Company, Sanofi-Aventis, Ypsomed Holding AG, Valeritas Inc., Proteus Digital Health Inc., Pear Therapeutics Inc., Huma Inc.

North America was the largest region in the drug infusion systems market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in the drug infusion systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the drug infusion systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The drug infusion systems market consists of sales of smart pumps, syringe pumps, enteral infusion systems, and topical infusion systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Drug Infusion Systems Market Characteristics

3. Drug Infusion Systems Market Trends And Strategies

4. Drug Infusion Systems Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Drug Infusion Systems Market Size and Growth

  • 5.1. Global Drug Infusion Systems Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Drug Infusion Systems Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Drug Infusion Systems Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Drug Infusion Systems Market Segmentation

  • 6.1. Global Drug Infusion Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Elastomeric Infusion System
  • Disposable Infusion System
  • Syringe Infusion System
  • Peristaltic Pump
  • Multi-Channel Pump
  • Patient-Controlled Analgesia (PCA) Pump
  • Insulin Pump
  • Implantable Infusion System
  • 6.2. Global Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Intravenous
  • Subcutaneous
  • Arterial
  • Epidural
  • Other Routes Of Administration
  • 6.3. Global Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oncology And Chemotherapy
  • Diabetes
  • Analgesia
  • Nutrition
  • Hematology
  • Pediatrics
  • Other Applications
  • 6.4. Global Drug Infusion Systems Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Other End Users

7. Drug Infusion Systems Market Regional And Country Analysis

  • 7.1. Global Drug Infusion Systems Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Drug Infusion Systems Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Drug Infusion Systems Market

  • 8.1. Asia-Pacific Drug Infusion Systems Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drug Infusion Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Drug Infusion Systems Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Drug Infusion Systems Market

  • 9.1. China Drug Infusion Systems Market Overview
  • 9.2. China Drug Infusion Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Drug Infusion Systems Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Drug Infusion Systems Market

  • 10.1. India Drug Infusion Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Drug Infusion Systems Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Drug Infusion Systems Market

  • 11.1. Japan Drug Infusion Systems Market Overview
  • 11.2. Japan Drug Infusion Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Drug Infusion Systems Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Drug Infusion Systems Market

  • 12.1. Australia Drug Infusion Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Drug Infusion Systems Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Drug Infusion Systems Market

  • 13.1. Indonesia Drug Infusion Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Drug Infusion Systems Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Drug Infusion Systems Market

  • 14.1. South Korea Drug Infusion Systems Market Overview
  • 14.2. South Korea Drug Infusion Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Drug Infusion Systems Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Drug Infusion Systems Market

  • 15.1. Western Europe Drug Infusion Systems Market Overview
  • 15.2. Western Europe Drug Infusion Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Drug Infusion Systems Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Drug Infusion Systems Market

  • 16.1. UK Drug Infusion Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Drug Infusion Systems Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Drug Infusion Systems Market

  • 17.1. Germany Drug Infusion Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Drug Infusion Systems Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Drug Infusion Systems Market

  • 18.1. France Drug Infusion Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Drug Infusion Systems Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Drug Infusion Systems Market

  • 19.1. Italy Drug Infusion Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Drug Infusion Systems Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Drug Infusion Systems Market

  • 20.1. Spain Drug Infusion Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Drug Infusion Systems Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Drug Infusion Systems Market

  • 21.1. Eastern Europe Drug Infusion Systems Market Overview
  • 21.2. Eastern Europe Drug Infusion Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Drug Infusion Systems Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Drug Infusion Systems Market

  • 22.1. Russia Drug Infusion Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Drug Infusion Systems Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Drug Infusion Systems Market

  • 23.1. North America Drug Infusion Systems Market Overview
  • 23.2. North America Drug Infusion Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Drug Infusion Systems Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Drug Infusion Systems Market

  • 24.1. USA Drug Infusion Systems Market Overview
  • 24.2. USA Drug Infusion Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Drug Infusion Systems Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Drug Infusion Systems Market

  • 25.1. Canada Drug Infusion Systems Market Overview
  • 25.2. Canada Drug Infusion Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Drug Infusion Systems Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Drug Infusion Systems Market

  • 26.1. South America Drug Infusion Systems Market Overview
  • 26.2. South America Drug Infusion Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Drug Infusion Systems Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Drug Infusion Systems Market

  • 27.1. Brazil Drug Infusion Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Drug Infusion Systems Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Drug Infusion Systems Market

  • 28.1. Middle East Drug Infusion Systems Market Overview
  • 28.2. Middle East Drug Infusion Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Drug Infusion Systems Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Drug Infusion Systems Market

  • 29.1. Africa Drug Infusion Systems Market Overview
  • 29.2. Africa Drug Infusion Systems Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Drug Infusion Systems Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Drug Infusion Systems Market Competitive Landscape And Company Profiles

  • 30.1. Drug Infusion Systems Market Competitive Landscape
  • 30.2. Drug Infusion Systems Market Company Profiles
    • 30.2.1. Medtronic plc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Baxter International Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. ICU Medical Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Becton Dickinson and Company
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Smiths Group plc
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Drug Infusion Systems Market Competitive Benchmarking

32. Global Drug Infusion Systems Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Drug Infusion Systems Market

34. Drug Infusion Systems Market Future Outlook and Potential Analysis

  • 34.1 Drug Infusion Systems Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Drug Infusion Systems Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Drug Infusion Systems Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer